Use of GabaB receptor agonists

Details Use of GabaB receptor agonists Use of GabaB receptor agonists

2006-04-07

2010-10-05

O'Sullivan, Peter G (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Phosphorus containing other than solely as part of an...

C564S015000

Reexamination Certificate

active

07807658

ABSTRACT:
Novel compounds of formula I, with the exception ofi) the racemate of (3-amino-2-hydroxypropyl)phosphinic acid; andii) (2R/S, 3R)-(3-amino-2-hydroxybutyl)phosphinic acid,having affinity to one or more GABABreceptors, their pharmaceutically acceptable salts, solvates and stereoisomers, as well as processes for their preparation, pharmaceutical compositions containing said therapeutically active compounds and the use of said active compounds in therapy.

REFERENCES:
patent: 4740332 (1988-04-01), Thottathil
patent: 5004826 (1991-04-01), Dingwall et al.
patent: 5036057 (1991-07-01), Martin
patent: 5229379 (1993-07-01), Marescaux et al.
patent: 5281747 (1994-01-01), Hall et al.
patent: 5332729 (1994-07-01), Mickel et al.
patent: 5407922 (1995-04-01), Marescaux et al.
patent: 5461040 (1995-10-01), Hall et al.
patent: 5538956 (1996-07-01), Minchin et al.
patent: 5567840 (1996-10-01), Hall et al.
patent: 6117908 (2000-09-01), Andrews et al.
patent: 6576626 (2003-06-01), Elebring et al.
patent: 6596711 (2003-07-01), Amin et al.
patent: 6841698 (2005-01-01), Elebring et al.
patent: 7034176 (2006-04-01), Elebring et al.
patent: 2005/0137414 (2005-06-01), Elebring et al.
patent: 449046 (1968-11-01), None
patent: 0181833 (1986-05-01), None
patent: 0356128 (1990-02-01), None
patent: 0399949 (1990-11-01), None
patent: 0463969 (1992-01-01), None
patent: 506853 (1992-10-01), None
patent: 2722192 (1996-01-01), None
patent: 8704077 (1987-07-01), None
patent: 9611680 (1996-04-01), None
patent: 9811885 (1998-03-01), None
Froestl, et al. (1995), J. Med. Chem., 38, 3297-3312.
Zukin, et al. (1974), Proc. Natl. Acad. USA 71, 4802-4807.
The GABA Receptors; Second Edition, Edited by S.J. Enna and Norman Bowery, Humana Press (1997), pp. 281-282.
CA:123:2568411 Abs of Journal of Med Chem by Froestl et al., 38917, pp. 3297-3312 (1995).
CA:112:118949 Abs of Tetrahedron by Dingwall et al., 45(12), pp. 3707-3808 (1989).
“GABABReceptors: Targets for Drug Development”, David I.B. Kerr and Jennifer Ong;DDT, vol. 1, No. 9; Sep. 1996; pp. 371-380.
“GABAA- and GABAB-Receptor Mediated Modification of Intestinal Motility”, Jennifer Ong and David I.B. Kerr;European Journal of Pharmacology; vol. 86, 1993; pp. 9-17.
Dingwall, J.G. et al., Diethoxymethylphosphonites and Phosphinates. Intermediates for the Synthesis of α, β- and γ-Aminoalkylphosphonous Acids,Tetrahedron, vol. 45, No. 12, pp. 3787-3808 (1989).
Hall, R..G., “Phosphinic Acid Analogues of γ-Aminobutyric acid (GABA). Synthesis of a New Radioligand”,Journal of Labelled Compounds and Radiopharmaceutics, vol. 36, No. 2, pp. 129-135 (1995).
Olpe et al. (1990), Eur. J. Pharmacol. 187, 27-38.
Holloway & Dent (1990), Gastroenterol. Clin. N. Amer. 19, 517-535.

Affiliated with

Also associated with

Rating

Use of GabaB receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of GabaB receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of GabaB receptor agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4186350